![Insights from 2023 ASCO® Annual Meeting](http://media.vumedi.com/thumbs/channel_logo/2023/5/a2df459d-f523-49c6-86db-fbc880f4b695.png.200x0_q85.png)
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Final Prespecified OS Analysis of CLEAR - 4-Year Follow-Up of Lenvatinib + Pembro vs. Sunitinib in Patients With Advanced RCC"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Thomas Hutson
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Thomas Hutson
300 views
June 27, 2023
Comments 0
Login to view comments.
Click here to Login
GU